REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 20 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,587,200 | -23.6% | 44,000,000 | 0.0% | 0.02% | -18.2% |
| Q2 2023 | $46,596,000 | -14.0% | 44,000,000 | 0.0% | 0.02% | -18.5% |
| Q1 2023 | $54,186,000 | +22.3% | 44,000,000 | -8.3% | 0.03% | +17.4% |
| Q4 2022 | $44,304,000 | -15.3% | 48,000,000 | 0.0% | 0.02% | -20.7% |
| Q3 2022 | $52,320,000 | +33.9% | 48,000,000 | 0.0% | 0.03% | +52.6% |
| Q2 2022 | $39,060,000 | -13.5% | 48,000,000 | 0.0% | 0.02% | +5.6% |
| Q1 2022 | $45,150,000 | +6.5% | 48,000,000 | 0.0% | 0.02% | +20.0% |
| Q4 2021 | $42,390,000 | -23.4% | 48,000,000 | 0.0% | 0.02% | -28.6% |
| Q3 2021 | $55,363,000 | -1.6% | 48,000,000 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $56,240,000 | +4.1% | 48,000,000 | 0.0% | 0.02% | -4.5% |
| Q1 2021 | $54,031,000 | – | 48,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| READYSTATE ASSET MANAGEMENT LP | 17,500,000 | $21,551,250 | 2.00% |
| CSS LLC/IL | 17,325,000 | $21,353,288 | 1.41% |
| SSI INVESTMENT MANAGEMENT LLC | 7,938,000 | $9,735,966 | 0.68% |
| Boussard & Gavaudan Investment Management LLP | 5,000 | $6,146,212 | 0.58% |
| Context Capital Management, LLC | 3,249 | $4,001 | 0.34% |
| LINDEN ADVISORS LP | 20,000,000 | $24,645,586 | 0.26% |
| AVIVA PLC | 22,325,000 | $27,381,613 | 0.12% |
| DeepCurrents Investment Group LLC | 2,384,000 | $2,931,980 | 0.11% |
| LAZARD ASSET MANAGEMENT LLC | 35,500,000 | $43,718 | 0.06% |
| D. E. Shaw & Co., Inc. | 34,364,000 | $42,380,365 | 0.04% |